MX2017001459A - Sintesis de fosforamidatos. - Google Patents
Sintesis de fosforamidatos.Info
- Publication number
- MX2017001459A MX2017001459A MX2017001459A MX2017001459A MX2017001459A MX 2017001459 A MX2017001459 A MX 2017001459A MX 2017001459 A MX2017001459 A MX 2017001459A MX 2017001459 A MX2017001459 A MX 2017001459A MX 2017001459 A MX2017001459 A MX 2017001459A
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- formula
- mixture
- phosphoramidates
- synthesis
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000008298 phosphoramidates Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000002841 Lewis acid Substances 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
- C07F9/6521—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
- C07F9/65324—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe un procedimiento para la preparación de un compuesto de la fórmula (I) incluyendo todos los isómeros, estereoisómeros, enantiómeros y diastereómeros del mismo, y sales del mismo; el procedimiento comprende proveer una mezcla que comprende un compuesto de la fórmula (II) y un compuesto de la fórmula (III), someter la mezcla provista en a) a condiciones de reacción en presencia de uno o más ácidos de Lewis a la mezcla provista en a), obteniendo una mezcla que comprende el compuesto de la fórmula (I).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14179385 | 2014-07-31 | ||
| PCT/EP2015/067720 WO2016016447A1 (en) | 2014-07-31 | 2015-07-31 | Synthesis of phosphoramidates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017001459A true MX2017001459A (es) | 2017-05-23 |
Family
ID=51257395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017001459A MX2017001459A (es) | 2014-07-31 | 2015-07-31 | Sintesis de fosforamidatos. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20170218006A1 (es) |
| EP (1) | EP3174892A1 (es) |
| JP (1) | JP2017522343A (es) |
| CN (1) | CN106661074A (es) |
| AU (1) | AU2015295274A1 (es) |
| BR (1) | BR112017001847A2 (es) |
| CA (1) | CA2954940A1 (es) |
| MX (1) | MX2017001459A (es) |
| WO (1) | WO2016016447A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ307789B6 (cs) * | 2014-04-15 | 2019-05-09 | Zentiva, K.S. | Způsob výroby biologicky účinných fosforamidátových léčiv |
| SI3524234T1 (sl) | 2014-06-13 | 2021-05-31 | Ratiopharm Gmbh | Trdne oblike sofosbuvira |
| CN105461774B (zh) * | 2014-09-30 | 2020-11-24 | 江苏豪森药业集团有限公司 | 索非布韦的制备方法 |
| WO2016064797A1 (en) * | 2014-10-20 | 2016-04-28 | Merck Sharp & Dohme Corp. | Process for making nucleoside phosphoramidate compounds |
| WO2016160646A1 (en) * | 2015-04-02 | 2016-10-06 | Merck Sharp & Dohme Corp. | Process for making phosphoramidate protected nucleoside compounds |
| US10676498B2 (en) | 2015-06-03 | 2020-06-09 | Teva Pharmaceuticals International Gmbh | Processes for the preparation of sofosbuvir and intermediates thereof |
| JP7337797B2 (ja) * | 2017-11-16 | 2023-09-04 | シンジェンタ パーティシペーションズ アーゲー | 鏡像異性的に及びジアステレオマー的に富化したシクロブタンアミン及びアミドの調製方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2794671C (en) * | 2010-03-31 | 2018-05-01 | Gilead Pharmasset Llc | Stereoselective synthesis of phosphorus containing actives |
| SI2609923T1 (sl) * | 2010-03-31 | 2017-10-30 | Gilead Pharmasset Llc | Postopek za kristalizacijo (s)-izopropil 2-(((s)-(perfluorofenoksi) (fenoksi)fosforil)amino)propanoata |
| RS56038B1 (sr) * | 2012-11-16 | 2017-09-29 | Univ College Cardiff Consultants Ltd | Smeša rp/sp gemcitabin-[fenil-(benziloksi-l-alaninil)]-fosfata |
| GB201221064D0 (en) * | 2012-11-23 | 2013-01-09 | Secr Defence | A deformable element |
| WO2014134146A1 (en) * | 2013-02-26 | 2014-09-04 | Jacobs Vehicle Systems, Inc. | Intra-cylinder auxiliary actuation of engine valves through selective discontinuation of main valve events |
| WO2014164533A1 (en) * | 2013-03-11 | 2014-10-09 | Vertex Pharmaceuticals Incorporated | Methods of stereoselective synthesis of substituted nucleoside analogs |
| AU2014250764A1 (en) * | 2013-04-12 | 2015-10-29 | Achillion Pharmaceuticals, Inc. | Deuterated nucleoside prodrugs useful for treating HCV |
| CA2986812A1 (en) * | 2015-05-26 | 2016-12-01 | Sandoz Ag | Selective process for synthesis of nucleoside phosphoramidates |
-
2015
- 2015-07-31 BR BR112017001847A patent/BR112017001847A2/pt not_active IP Right Cessation
- 2015-07-31 US US15/500,627 patent/US20170218006A1/en not_active Abandoned
- 2015-07-31 EP EP15752965.2A patent/EP3174892A1/en not_active Withdrawn
- 2015-07-31 MX MX2017001459A patent/MX2017001459A/es unknown
- 2015-07-31 CN CN201580036548.4A patent/CN106661074A/zh not_active Withdrawn
- 2015-07-31 WO PCT/EP2015/067720 patent/WO2016016447A1/en not_active Ceased
- 2015-07-31 JP JP2017505106A patent/JP2017522343A/ja active Pending
- 2015-07-31 CA CA2954940A patent/CA2954940A1/en not_active Abandoned
- 2015-07-31 AU AU2015295274A patent/AU2015295274A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN106661074A (zh) | 2017-05-10 |
| US20170218006A1 (en) | 2017-08-03 |
| WO2016016447A1 (en) | 2016-02-04 |
| BR112017001847A2 (pt) | 2018-02-27 |
| EP3174892A1 (en) | 2017-06-07 |
| CA2954940A1 (en) | 2016-02-04 |
| AU2015295274A1 (en) | 2017-01-12 |
| JP2017522343A (ja) | 2017-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017001459A (es) | Sintesis de fosforamidatos. | |
| NZ726356A (en) | Processes for preparing antiviral compounds | |
| MX377552B (es) | Proceso para preparar un compuesto antiviral de formula i. | |
| BR112016029333A2 (pt) | síntese de compostos de carbamoilpiridona policíclico | |
| MX2021014128A (es) | Polimorfos de selinexor. | |
| CR20170443A (es) | Análogos de nucleósido 5´-sustituidos | |
| PH12019502093A1 (en) | Novel ester compounds, method for the production thereof and use thereof | |
| PH12016502229A1 (en) | Process for preparing phosphorus-containing cyanohydrins | |
| NZ711192A (en) | Process for making benzoxazepin compounds | |
| JO3372B1 (ar) | مشتقات 5-بنزيل إيزوكينولين لعلاج أمراض القلب والأوعية الدموية | |
| MX2017008280A (es) | Proceso para elaborar cenicriviroc y analogos relacionados. | |
| PH12018550165A1 (en) | An improved process for the preparation of butorphanol tartrate | |
| NZ720106A (en) | A process for the preparation of regadenoson | |
| IN2014MU01192A (es) | ||
| MX2017012027A (es) | Desaminacion de nucleosidos organofosforados. | |
| IN2014MU00195A (es) | ||
| SG10201901578UA (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
| IN2013MU00916A (es) | ||
| MX2018008718A (es) | Metodo para la preparacion de 2-aril-etanoles sustituido. | |
| WO2015196121A3 (en) | Method of treating ovarian cancer using a pkc inhibitor | |
| GB2564185A (en) | Process for the preparation of derivatives of benzodioxole | |
| IN2014MU00194A (es) | ||
| IN2014MU01196A (es) | ||
| IN2013MU01219A (es) | ||
| IN2014CH00444A (es) |